|
DT:
Diphtheria, Tetanus Toxoids—Pediatric
Td: Tetanus, Diphtheria Toxoids—Adult |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at
35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures.
Refrigerate upon arrival.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F
(2° to 8°C). Do not freeze or expose to freezing
temperatures.
Shelf
Life
Check expiration date on vial or manufacturer-filled syringe.
Instructions
for Use
Inspect visually for extraneous particulate matter and/or discoloration.
If these conditions exist, the vaccine should not be used. Shake
vial or manufacturer-filled syringe well before use. Discard vaccine
if it cannot be resuspended with thorough agitation. |
|
Shelf
Life After Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Multidose Vials:
Withdraw single dose of vaccine into separate sterile needle and
syringe for each immunization. The vaccine should be administered
shortly after withdrawal from the vial. Unused portions of multidose
vials may be refrigerated at 35° – 46°F (2° – 8°C) and
used until expired, if not contaminated or unless otherwise stated
in the manufacturer's product information.
Manufacturer-Filled
Syringes: The vaccine should be administered shortly after
the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
DTaP:
Diphtheria Toxoid, Tetanus Toxoid, Acellular
Pertussis Vaccine—Pediatric
DTaP/Hib: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine Combined with Haemophilus influenzae type b Conjugate Vaccine*—Pediatric
DTaP/HepB/IPV: Diphtheria Toxoid, Tetanus Toxoid, Acellular Pertussis Vaccine, Hepatitis B Vaccine, Inactivated Polio Vaccine—Pediatric
Tdap: Tetanus
Toxoid, Diphtheria Toxoid, Acellular Pertussis Vaccine—Adult
|
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at
35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Shelf Life
Check expiration date on vial, container, or manufacturer-filled syringe. |
|
Instructions
for Reconstitution* or Use
Shake well before withdrawal and use. Do not use if resuspension
does not occur with vigorous shaking.
Shelf Life After Reconstitution* or Opening
Single-Dose Vials: The vaccine should be administered shortly after withdrawal from the vial.
Manufacturer-Filled Syringes: The vaccine should be administered shortly after the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details. |
* DTaP/Hib (TriHIBit®)
is ActHIB®
(sanofi pasteur) reconstituted with Tripedia®
(sanofi pasteur). Once reconstituted, this combination vaccine must
be used within 30 minutes or discarded. The only DTaP vaccine that
can be used to reconstitute ActHIB®
is Tripedia®.
No other brand of DTaP is approved for this use.
|
Hepatitis
Vaccines:
Hepatitis A, Hepatitis B, Hepatitis A/B,
Hepatitis B/Haemophilus influenzae type b |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F
(2° to 8°C). Do not freeze or expose to freezing
temperatures.
Shelf
Life
Check expiration date on vial or manufacturer-filled syringe.
|
|
Instructions
for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation.
Shelf
Life After Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Manufacturer-Filled Syringes: The vaccine should
be administered shortly after the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details. |
Hib:
Haemophilus influenzae type b Conjugate
Vaccine |
Shipping Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Refrigerate immediately upon arrival.
Store at 35° to 46°F (2° to 8°C). Do not
freeze or expose to freezing temperatures.
Diluent: May be refrigerated or stored at room
temperature (68° – 77°F [20° – 25°C]). Do not freeze or expose to freezing
temperatures.
|
|
Shelf Life
Check expiration date on vial or container.
Instructions
for Reconstitution* or Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial well before use. Discard vaccine if it cannot be resuspended with thorough agitation.
Shelf
Life After Reconstitution* or Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
*
ActHIB® (sanofi pasteur) reconstituted with 0.4% sodium
chloride diluent should be used within 24 hours after reconstitution.
If sanofi pasteur DTaP-Tripedia® is used to reconstitute
ActHIB®, the TriHibit® vaccine must be used
within 30 minutes of reconstitution. Only sanofi pasteur DTaP-Tripedia®
or the diluent shipped with the product may be used to reconstitute
the sanofi pasteur ActHIB® product. No other brand of DTaP
is licensed for use in reconstitution of ActHIB®. |
HPV:
Human Papillomavirus Vaccine |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F (2°
to 8°C). Do not freeze or expose to freezing temperatures.
Protect from light at all times.
Shelf
Life
Check expiration date on vial or manufacturer-filled syringe. |
|
Instructions
for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation.
Shelf
Life After Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Manufacturer-Filled Syringes: The vaccine should
be administered shortly after the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
IPV:
Inactivated Polio Vaccine |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to
freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F
(2° to 8°C). Do not freeze or expose to freezing
temperatures.
Shelf Life
Check expiration date on vial or manufacturer-filled syringe.
Instructions for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation. |
|
Shelf
Life After Opening
Multidose Vials: Withdraw single dose of vaccine
into separate sterile needle and syringe for each immunization.
The vaccine should be administered shortly after withdrawal from
the vial. Unused portions of multidose vials may be refrigerated
at 35° – 46°F (2° – 8°C) and used until expired, if
not contaminated or unless otherwise stated in the manufacturer's
product information.
Manufacturer-Filled Syringes:
The vaccine should be administered shortly after the needle is attached
to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
TIV:
Trivalent Inactivated Influenza Vaccine |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at
35° to 46°F (2°
to 8°C). Do not freeze or expose to freezing temperatures.
Condition upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F (2°
to 8°C). Do not freeze or expose to freezing temperatures.
Protect Fluarix® and FluLaval™ from light at all times
by storing in original package.
Shelf Life
Formulated for use during current influenza season. Check expiration date on vial or manufacturer-filled syringe. |
|
Instructions
for Use
Inspect visually for extraneous particulate matter and/or discoloration.
If these conditions exist, the vaccine should not be used. Shake
vial or manufacturer-filled syringe well before use. Discard vaccine
if it cannot be resuspended with thorough agitation.
Shelf
Life After Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Multidose Vials:
Withdraw single dose of vaccine into separate sterile needle
and syringe for each immunization. The vaccine should be administered
shortly after withdrawal from the vial. Unused portions of multidose
vials may be refrigerated at 35° – 46°F (2° – 8°C) and
used until expired, if not contaminated or unless otherwise stated
in the manufacturer's product information.
Manufacturer-Filled
Syringes: The vaccine should be administered shortly after
the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
LAIV:
Live Attenuated Influenza Vaccine |
Shipping
Requirements
Initially shipped to authorized distributors in the frozen state
5°F (-15°C). Shipped from the distributor to healthcare facilities
in the refrigerated state at 35° – 46°F (2° – 8°C).
Condition
upon Arrival
Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° – 46°F
(2° – 8°C). Do not freeze or expose to freezing
temperatures. (If LAIV is inadvertently frozen, the vaccine
should be moved immediately to the refrigerator and may be used
until the expiration date printed on the package.)
|
|
Shelf
Life
Formulated for use during current influenza season. Check expiration
date on package.
Instructions
for Use
LAIV is a colorless to pale yellow liquid and is clear to slightly
cloudy; some particulates may be present but do not affect the use
of the product. After removal of the sprayer from the refrigerator,
remove the rubber tip protector. Follow manufacturer’s instructions
to deliver ½ dose into one nostril. Then remove the dose-divider
clip and deliver the remainder of the dose into the other nostril.
Shelf
Life After Opening
Single-Dose Sprayer: The vaccine should be administered
shortly after removal from the refrigerator.
Special Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
MMR:
Measles/Mumps/Rubella Vaccine,
MR: Measles/Rubella Vaccine, Measles Virus Vaccine,
Mumps Virus Vaccine, Rubella Virus Vaccine |
Shipping
Requirements
Vaccine: Should be shipped in insulated container. Must be shipped
with refrigerant. Maintain at 50°F (10°C) or less. If shipped
with dry ice, diluent must be shipped separately.
Diluent: May be shipped with vaccine,
but do not place in container with dry ice.
Condition
upon Arrival
Maintain at 50°F (10° C) or less. If above this temperature,
see instructions (*) below. Do not use warm vaccine.
Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Refrigerate immediately upon arrival.
Store at 35° to 46°F (2° to 8°C). Protect from light
at all times, since such exposure may inactivate the virus.
Diluent: May be refrigerated or stored
at room temperature (68° to 77°F [20° to 25°C]).
Do not freeze or expose to freezing temperatures.
Note: MMR vaccine may be stored in the refrigerator or freezer.
|
|
Shelf
Life
Check expiration date on vial.
Instructions
for Reconstitution and Use
Reconstitute just before use according to the manufacturer’s instructions. Use only the diluent supplied to reconstitute the vaccine.
Shelf
Life After Reconstitution, Thawing or Opening
Single-Dose Vials: After reconstitution, use immediately or store at 35° – 46°F (2° – 8°C) and protect from light. Discard if not used within 8 hours of reconstitution.
Multidose vials: Withdraw single dose of reconstituted vaccine into separate sterile needle and syringe for each immunization. The vaccine dose should be administered shortly after withdrawal from vial. Unused portions of multidose vials may be refrigerated at 35° – 46°F (2° – 8°C), but must be discarded if not used within 8 hours after reconstitution.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
MMRV:
Measles/Mumps/Rubella/Varicella Vaccine |
Shipping
Requirements
Vaccine: Should be shipped in insulated container. Must be shipped with dry ice only, at 5°F (-15°C) or colder. Should be delivered within 2 days.
Diluent: May be shipped with vaccine,
but do not place in container with dry ice.
Condition
upon Arrival
Should be frozen. Vaccine should remain at 4°F (-20°C) or
colder until arrival at the
healthcare facility. Dry ice should still be present in the shipping
container when vaccine is delivered.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Freeze immediately upon arrival. Maintain vaccine in a continuously frozen
state at 5°F (-15°C) or colder. No freeze/thaw cycles are allowed with this vaccine. Vaccine should only be stored in freezers or refrigerator/freezers with separate doors and compartments. Acceptable storage may be achieved in standard household freezers purchased
in the last 10 years, and standard household refrigerator/freezers with a separate, sealed freezer compartment. “Dormitory-style units” are not appropriate for the storage of MMRV vaccine. Do
not store lyophilized vaccine in the refrigerator. If lyophilized vaccine is inadvertently stored in the refrigerator, it should be used within 72 hours. Lyophilized vaccine stored at 35° – 46°F (2° – 8°C) which is not used within 72 hours should be discarded.
Protect the vaccine from light at all times since such exposure may inactivate the vaccine viruses.
|
|
In order to maintain temperatures of 5°F (-15°C) or colder, it will be necessary in most refrigerator/ freezer models to turn the temperature dial down to the coldest setting. This may result in the refrigerator compartment temperature being lowered as well. Careful monitoring of the refrigerator temperature will be necessary to avoid freezing killed or inactivated vaccines.
Diluent: May be refrigerated or stored at room
temperature (68° to 77°F [20° to 25°C]). Do
not freeze or expose to freezing temperatures.
Shelf
Life
Check expiration date on vial.
Instructions
for Reconstitution and Use
Reconstitute just before use according to the manufacturer’s instructions. Use only the diluent supplied to
reconstitute the vaccine.
Shelf
Life After Reconstitution, Thawing or Opening
Single-Dose Vials: Discard reconstituted vaccine if it is not used within 30 minutes of reconstitution. Do not freeze reconstituted vaccine.
Special
Instructions
If this vaccine is stored at a temperature warmer than 5°F (-15°C), it will result in a loss of potency and a reduced shelf life. If a power outage or some other situation occurs that results in the vaccine storage temperature rising above the recommended temperature, the healthcare provider should contact Merck, the vaccine manufacturer, at 1-800-MERCK-90 for an evaluation of the product potency before using the vaccine.
Note: All vaccine materials should be disposed of using medical waste disposal procedures. Contact the state health department for details.
|
MCV:
Meningococcal Conjugate Vaccine |
Shipping Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures.
Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F (2° to 8°C). Do not freeze
or expose to freezing temperatures.
Shelf Life
Check expiration date on vial or manufacturer-filled syringe. |
|
Instructions for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation.
Shelf Life After Opening
Single-Dose Vials: The vaccine should be administered shortly after withdrawal from the vial.
Manufacturer-Filled Syringes: The vaccine should be administered shortly after the needle is attached to the syringe.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Vaccine should be injected by the intramuscular route. Do not inject intradermally,
subcutaneously, or intravenously.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
MPSV:
Meningococcal Polysaccharide Vaccine |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Refrigerate immediately upon arrival. Store at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Diluent: May be refrigerated or stored at room temperature (68° – 77°F [20° – 25°C]). Do not freeze or expose to freezing temperatures.
Shelf
Life
Check expiration date on vial.
|
|
Instructions for Reconstitution and Use
Reconstitute gently. This is a white
powder that yields a clear, colorless
liquid when reconstituted with 0.6 ml (single-dose vial) or 6 ml (10-dose vial)
of sterile distilled water.
Shelf
Life After Reconstitution or Opening
Single-Dose Vials: Use within 30 minutes of reconstitution.
Multidose Vials:
Unused portions of multidose vials may be refrigerated at 35°
to 46°F (2° to 8°C) and used up to 35 days after reconstitution.
Special
Instructions
Rotate stock so that
the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details. |
PCV:
Pneumococcal Conjugate Vaccine |
Shipping Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Shelf Life
Check expiration date on vial or manufacturer-filled syringe.
|
|
Instructions for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation.
Shelf Life After Opening
Single-Dose Vials: The vaccine should be administered shortly after withdrawal from the vial.
Manufacturer-Filled Syringes: The vaccine should be administered shortly after the needle is attached to the syringe.
Special
Instructions
This vaccine is a suspension containing adjuvant and should not
be used if the particles cannot be resuspended after vigorous shaking.
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
PPV:
Pneumococcal Polysaccharide Vaccine |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F
(2° to 8°C). Do not freeze or expose to freezing
temperatures.
Shelf
Life
Check expiration date on vial.
Instructions for Use
Inspect visually for extraneous particulate matter and/or discoloration. If these conditions exist, the vaccine should not be used. Shake vial or manufacturer-filled syringe well before use. Discard vaccine if it cannot be resuspended with thorough agitation. |
|
Shelf
Life After Opening
Single-Dose Vials: The vaccine should be administered
shortly after withdrawal from the vial.
Multidose Vials: Withdraw single dose of vaccine into separate sterile needle and syringe for each immunization. The vaccine should be administered shortly after withdrawal from the vial. Unused portions of multidose vials may be refrigerated at 35° – 46°F (2° – 8°C) and used until expired, if not contaminated or unless otherwise stated in the manufacturer’s product information.
Special
Instructions
Do not inject intravenously. Intradermal administration may cause
severe local reactions and should be avoided. Rotate stock so that
the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details. |
Shipping
Requirements
Should be shipped in insulated container. Maintain temperature at 35° to 46°F (2° to 8°C). Do not freeze or expose to freezing temperatures.
Condition
upon Arrival
Should not have been frozen or exposed to freezing temperatures. Refrigerate upon arrival.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Refrigerate immediately upon arrival. Store at 35° to 46°F
(2° to 8°C). Do not freeze or expose to freezing
temperatures. Protect from light at all times, since such exposure may inactivate the vaccine viruses.
Shelf
Life
Check expiration date on package.
|
|
Instructions
for Use
Each dose is supplied in a container consisting of a squeezable
plastic, latex-free dosing tube with a twist-off cap, allowing for
direct oral administration. The dosing tube is contained in a pouch.
Remove the dosing tube from the pouch, screw the cap clockwise to
puncture the tube, and screw the cap off counter-clockwise so that
the liquid can be squeezed from the tube during oral administration
of the vaccine.
Shelf
Life After Opening
Single-Dose Pouches: The vaccine should be administered
shortly after withdrawal from the refrigerator. The dosing tube
should not be returned to the refrigerator once the screw cap has
been removed.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
Varicella
(Chickenpox) Vaccine |
Shipping
Requirements
Vaccine: Use insulated container. Must be shipped with dry ice only, at 5°F (-15°C) or colder. Should be delivered within 2 days.
Diluent: May be shipped with vaccine, but do not place in container with dry ice.
Condition
upon Arrival
Should be frozen. Vaccine should remain at 5°F (-15°C) or colder until arrival at the healthcare facility. Dry ice should still be present in the shipping container when vaccine is delivered.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Freeze immediately upon arrival. Maintain vaccine in a continuously frozen state at 5°F (-15°C) or colder. No freeze/thaw cycles are allowed with this vaccine. Vaccine should only be stored in freezers or refrigerator/freezers with separate external doors and compartments. Acceptable storage may be achieved in standard household freezers purchased in the last 10 years, and standard household refrigerator/freezers with a separate, sealed freezer compartment. "Dormitory-style" units are not appropriate for the storage of varicella vaccine. Do not store lyophilized vaccine in the refrigerator. If lyophilized vaccine is inadvertently stored in the refrigerator, it should be used within 72 hours. Lyophilized vaccine stored at 35° – 46°F (2° – 8°C) which is not used within 72 hours, should be discarded. Protect the vaccine from light at all times since such exposure may inactivate the vaccine virus.
|
|
In order to maintain temperatures of 5°F (-15°C) or colder, it will be necessary in most refrigerator/freezer models to turn the temperature dial down to the coldest setting. This may result in the refrigerator compartment temperature being lowered as well. Careful monitoring of the refrigerator temperature will be
necessary to avoid freezing killed or inactivated vaccines.
Diluent: May be refrigerated or stored at room temperature (68° to 77°F [20° to 25°C]). Do not freeze or expose to freezing temperatures.
Shelf
Life
Check expiration date on vial.
Instructions
for Reconstitution and Use
Reconstitute just before use according to the manufacturer’s instructions. Use only the diluent supplied to reconstitute the vaccine.
Shelf
Life After Reconstitution, Thawing or Opening
Single-Dose Vials: Discard reconstituted vaccine if it is not used within 30 minutes of reconstitution. Do not freeze reconstituted vaccine.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
If this vaccine is stored at a temperature warmer than 5°F (-15°C), it will result in a loss of potency and a reduced shelf life. If a power outage or some other situation occurs that results in the vaccine storage temperature rising above the recommended temperature, the healthcare provider should contact Merck, the vaccine manufacturer, at 1-800-9-VARIVAX for a reevaluation of the product potency before using the vaccine.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
Zoster
(Shingles) Vaccine |
Shipping
Requirements
Vaccine: Should be shipped in insulated container. Must be shipped with dry ice only, at 5°F (-15°C) or colder. Should be delivered within 2 days.
Diluent: May be shipped with vaccine, but do not place in container with dry ice.
Condition
upon Arrival
Should be frozen. Vaccine should remain at 5°F (-15°C) or colder until arrival at the healthcare facility. Dry ice should still be present in the shipping container when vaccine is delivered.
If you have questions about the condition of the material at the
time of delivery, you should 1) immediately place material in recommended
storage; and 2) then follow your state health department immunization
program policy and contact either the Manufacturer's
Quality Control office or the immunization program for guidance.
Storage
Requirements
Vaccine: Freeze immediately upon arrival. Maintain vaccine in a continuously frozen state at 5°F (-15°C) or colder. No freeze/thaw cycles are allowed with this vaccine. Vaccine should only be stored in freezers or refrigerator/freezers with separate doors and compartments. Acceptable storage may be achieved in standard household freezers purchased in the last 10 years, and standard household refrigerator/freezers with a separate, sealed freezer compartment. “Dormitory-style units” are not appropriate for the storage of zoster vaccine. Do not store lyophilized vaccine in the refrigerator.
Protect the vaccine from light at all times since such exposure may inactivate the vaccine viruses.
In order to maintain temperatures of 5°F (-15°C) or colder, it will be necessary in most refrigerator/freezer models to turn the temperature dial down to the coldest setting. This may result in the refrigerator compartment temperature being lowered as well. Careful monitoring of the refrigerator temperature will be necessary to avoid freezing killed or inactivated vaccines.
|
|
Diluent: May be refrigerated or stored at room temperature (68° to 77°F [20° to 25°C]). Do not freeze or expose to freezing temperatures.
Shelf
Life
Check expiration date on vial.
Instructions
for Reconstitution and Use
Reconstitute just before use according to the manufacturer’s instructions. Use only the diluent supplied to reconstitute the vaccine.
Shelf
Life After Reconstitution, Thawing or Opening
Discard reconstituted vaccine if it is not used within 30 minutes of reconstitution. Do not freeze reconstituted vaccine.
Special
Instructions
Rotate stock so that the earliest dated material is used first.
If this vaccine is stored at a temperature warmer than 5°F (-15°C), it will result in a loss of potency and a reduced shelf life. If a power outage or some other situation occurs that results in the vaccine storage temperature rising above the recommended temperature, the healthcare provider should contact Merck, the vaccine manufacturer, at 1-800-MERCK-90 for a reevaluation of the product potency before using the vaccine.
Note: All vaccine materials should be disposed
of using medical waste disposal procedures. Contact the state health
department for details.
|
|